SENSEX 61,175.95
-132.96 (-0.22%)

NIFTY 50 18,254.05
-54.05 (-0.3%)

NIFTY AUTO 11,772.4
-108.85 (-0.92%)

Dr Reddys Laboratories Ltd

NSE :DRREDDY BSE :500124 Sector : Pharmaceuticals

Buy, Sell or Hold DRREDDY? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

17 Jan
4672.40
(-0.36%)

14 Jan
4689.20
(-0.78%)

13 Jan
4725.95
(0.69%)

12 Jan
4693.40
(0.52%)

11 Jan
4669.25
(-0.63%)

10 Jan
4699.05
(-0.20%)

07 Jan
4708.40
(-0.66%)

06 Jan
4739.45
(-1.06%)

05 Jan
4790.40
(-0.93%)

04 Jan
4835.45
(-0.36%)

03 Jan
4853.15
(-1.10%)

31 Dec
4907.00
(0.05%)

30 Dec
4904.70
(1.48%)

29 Dec
4833.15
(1.88%)

28 Dec
4743.80
(0.15%)

27 Dec
4736.90
(2.12%)

24 Dec
4638.65
(-1.20%)

23 Dec
4694.80
(1.00%)

22 Dec
4648.50
(0.60%)

21 Dec
4620.90
(1.32%)

20 Dec
4560.70
(0.95%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bearish

Medium Term Investors

Neutral

Long Term Investors

Very Bearish

Moving Averages

5 DMA

Bearish

4689.96

10 DMA

Bearish

4721.73

20 DMA

Bearish

4740.19

50 DMA

Bearish

4694.7

100 DMA

Bearish

4755.04

200 DMA

Bearish

4932.88

Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Jan 17, 2022 04:00 PM For Next Trading Session

Pivots	Classic	Fibonacci	Camarilla	Woodie	DM
R3	4807.51	4753.73	4698.37	-	-
R2	4753.73	4717.65	4689.72	4757.01	-
R1	4713.06	4695.36	4681.06	4719.62	4733.4
P	4659.28	4659.28	4659.28	4662.56	4669.45
S1	4618.61	4623.2	4663.74	4625.17	4638.95
S2	4564.83	4600.91	4655.08	4568.11	-
S3	4524.16	4564.83	4646.43	-	-

Key Metrics

EPS

97.2

P/E

48.08

P/B

4.45

Dividend Yield

0.53%

Market Cap

77,757 Cr.

Face Value

5

Book Value

1049.62

ROE

11.74%

EBITDA Growth

1,589 Cr.

Debt/Equity

0.16

Shareholding Pattern

	26.72%	Total Promoter Holding

	12.17%	Mutual Fund Holdings

	27.76%	FIIs

	23.83%	Non Institution

	8.64%	Insurance Companies

	0.29%	Custodians

	0.59%	Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Quaterly Results

	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021
INCOME	4969.4	5027.5	4868.7	5069.6	6017.1
PROFIT	771.8	27.9	557.3	380.4	995.8
EPS	46.54	1.68	33.61	22.95	60.03

Dr Reddys Laboratories Ltd Quaterly Results

	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021
INCOME	3372.4	3471	3432.3	3619.7	3941.5
PROFIT	481	443.7	311.5	413.4	449
EPS	29	26.74	18.78	24.94	27.07

Profit & Loss (Figures in Rs. Crores)

Consolidated
Standalone

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021
INCOME	10099.4	12151	13904.6	15353.2	15959	14490.9	14477.7	16104.9	18170	20177.4
PROFIT	1392.03	1514.4	1945.62	2291.79	2071.62	1252.3	892.34	1849.63	2030.35	1954.44
EPS	74.48	87.37	112.29	133.04	123.55	75.83	54.96	117.47	121.9	117.28

Dr Reddys Laboratories Ltd Profit & Loss

	Mar 2012	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021
INCOME	6926.3	8612.7	10050.1	10262.7	10645.6	10309.1	9614.9	10797.9	12693.5	14545.8
PROFIT	903.32	1251.28	1926.89	1634.01	1320.26	1406.23	536.19	1274.22	2948.85	1849.38
EPS	51.57	71.98	113.56	94.48	80.56	83.48	34.15	76.95	176.76	131.39

Balance Sheet (Figures in Rs. Crores)

Consolidated
Standalone

	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
SOURCES OF FUNDS :
Share Capital	83.2	83.1	83	83	82.9	85.3	85.2	85.1	84.9	84.8
Reserves Total	17,755.2	15,616.3	13,994.1	12,488.6	12,179.2	12,484.5	9,767.9	7,780.1	6,284.2	4,904.2
Equity Application Money	-196.7	-100.6	-53.5	0	0	0	0	0	0	0
Total Shareholders Funds	17,641.7	15,598.8	14,023.6	12,571.6	12,262.1	12,569.8	9,853.1	7,865.2	6,369.1	4,989
Secured Loans	336.3	178.7	60.9	69.3	70.7	85.7	86.2	104.7	88.2	33.8
Unsecured Loans	2,694.5	2,031.5	3,777.2	5,002.1	4,847.8	3,266.4	4,227.9	4,372.3	3,594	3,200.1
Total Debt	3,030.8	2,210.2	3,838.1	5,071.4	4,918.5	3,352.1	4,314.1	4,477	3,682.2	3,233.9
Other Liabilities	212.5	280	297.4	375	427.6	344.5	351.2	174.4	86.4	82.8
Total Liabilities	20,885	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7	8,305.7
APPLICATION OF FUNDS :
Gross Block	18,555.7	16,108.2	14,998.6	17,436.3	15,932.4	15,019.7	12,573.6	11,917.6	10,089.4	8,842.3
Less: Accumulated Depreciation	10,350	9,257.9	7,807.6	10,468.3	9,001.7	8,456.7	7,196.6	7,276.8	6,038.8	5,430.6
Net Block	8,205.7	6,850.3	7,191	6,968	6,930.7	6,563	5,377	4,640.8	4,050.6	3,411.7
Capital Work in Progress	1,565.1	1,535.1	2,933.5	3,470.5	3,324.5	772.2	529	638.8	565.3	708.5
Investments	2,807.7	2,677.8	2,587.1	2,298.3	2,109.7	3,833.1	2,247.8	1,066.8	197	207.9
Inventories	4,541.2	3,506.7	3,357.9	2,908.9	2,852.8	2,557.9	2,569.9	2,418.8	2,170.7	1,943.3
Sundry Debtors	4,964.1	5,027.8	3,986.9	4,052.7	3,798.6	4,125	4,101.2	3,325.3	3,180.4	2,536.8
Cash and Bank Balance	1,482.9	205.3	222.8	263.8	386.5	492.1	1,872.4	2,300.6	2,017.1	1,606.1
Loans and Advances	1,587.7	1,490.6	1,289.6	1,440	1,218.7	1,115.6	1,231	1,214.6	961.9	705.8
Total Current Assets	12,575.9	10,230.4	8,857.2	8,665.4	8,256.6	8,290.6	9,774.5	9,259.3	8,330.1	6,792
Current Liabilities	5,062.6	4,610.2	3,762.2	3,739.6	3,385.6	3,304.6	2,794.8	2,573.2	2,568.4	2,502.6
Provisions	640.3	524.1	497	591.7	660.7	759.4	1,143.9	815.7	674.1	496.8
Total Current Liabilities & Provisions	5,702.9	5,134.3	4,259.2	4,331.3	4,046.3	4,064	3,938.7	3,388.9	3,242.5	2,999.4
Net Current Assets	6,873	5,096.1	4,598	4,334.1	4,210.3	4,226.6	5,835.8	5,870.4	5,087.6	3,792.6
Deferred Tax Assets	1,068.6	1,219.9	431.7	540.5	678.4	590.5	260.5	191.7	174.2	245.7
Deferred Tax Liability	28.9	2	47.3	195	162	53.7	156.2	124.1	107	130.8
Net Deferred Tax	1,039.7	1,217.9	384.4	345.5	516.4	536.8	104.3	67.6	67.2	114.9
Other Assets	393.8	711.8	465.1	601.6	516.6	334.7	424.5	232.2	170	70.1
Total Assets	20,885	18,089	18,159.1	18,018	17,608.2	16,266.4	14,518.4	12,516.6	10,137.7	8,305.7
Contingent Liabilities	0	0	138	277.57	102.17	92.17	190	221.6	112.6	178.7

	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
SOURCES OF FUNDS :
Share Capital	83.2	83.1	83	83	82.9	85.3	85.2	85.1	84.9	84.8
Reserves Total	17,097.2	15,209.4	12,654.6	11,724.8	11,517.7	11,993.1	10,548.8	9,243.9	7,698.5	6,633
Equity Application Money	-196.7	-100.6	-53.5	0	0	0	0	0	0	0
Total Shareholders Funds	16,983.7	15,191.9	12,684.1	11,807.8	11,600.6	12,078.4	10,634	9,329	7,783.4	6,717.8
Secured Loans	17.7	19.3	0	0	0	0.9	1.4	1.7	4.7	2.3
Unsecured Loans	1,196.8	1,437.6	1,064.6	2,588.8	2,355.2	3,084.2	3,124.7	2,664.5	2,095.3	1,533.1
Total Debt	1,214.5	1,456.9	1,064.6	2,588.8	2,355.2	3,085.1	3,126.1	2,666.2	2,100	1,535.4
Other Liabilities	67.9	84.1	83.2	84.6	103.4	123.6	75.3	38.2	32.6	27.5
Total Liabilities	18,266.1	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916	8,280.7
APPLICATION OF FUNDS :
Gross Block	12,345	10,215.9	9,774.1	9,223.6	8,675.4	7,580	5,815.6	4,899.7	4,208.7	3,507.8
Less : Accumulated Depreciation	6,500.7	5,782	5,091.4	4,506.3	3,833.3	3,141.9	2,566.2	2,151.4	1,821.7	1,611
Net Block	5,844.3	4,433.9	4,682.7	4,717.3	4,842.1	4,438.1	3,249.4	2,748.3	2,387	1,896.8
Capital Work in Progress	900.8	411.8	400.1	675	540	616.1	488.3	576.1	423.2	617.6
Investments	4,989.4	5,485.5	3,933.5	3,636.5	3,101.9	5,076.1	3,862.3	2,806.5	2,379.2	2,477.7
Inventories	2,819.7	2,190.4	2,015.6	1,856.8	1,809.7	1,699.6	1,723.3	1,592.1	1,526.5	1,326.7
Sundry Debtors	4,080	4,638.7	3,717.7	4,203.8	4,405.4	3,889.5	4,711.7	4,561.5	2,963.9	1,943.5
Cash and Bank Balance	1,306.3	39.2	113.2	120.7	66.8	202.1	901.4	665.1	919.1	849
Loans and Advances	1,141	1,120	972.3	1,174.4	1,012.8	1,121.9	964.7	1,022.7	994.1	597.5
Total Current Assets	9,347	7,988.3	6,818.8	7,355.7	7,294.7	6,913.1	8,301.1	7,841.4	6,403.6	4,716.7
Current Liabilities	3,064.8	2,535.6	2,175.4	2,445.7	2,179.6	2,127.5	1,952.1	1,870	1,558	1,715.8
Provisions	298.7	207.3	184.7	173.4	208.4	170.6	539.5	479.5	421.4	324.1
Total Current Liabilities & Provisions	3,363.5	2,742.9	2,360.1	2,619.1	2,388	2,298.1	2,491.6	2,349.5	1,979.4	2,039.9
Net Current Assets	5,983.5	5,245.4	4,458.7	4,736.6	4,906.7	4,615	5,809.5	5,491.9	4,424.2	2,676.8
Deferred Tax Assets	575.6	867.3	214.1	346.5	382.8	306	35.7	23.1	32.5	82.1
Deferred Tax Liability	320.8	254.4	269.6	253.4	300.7	242.5	164.7	148.3	126.2	102.1
Net Deferred Tax	254.8	612.9	-55.5	93.1	82.1	63.5	-129	-125.2	-93.7	-20
Other Assets	293.3	543.4	412.4	622.7	586.4	478.3	554.9	535.8	396.1	631.8
Total Assets	18,266.1	16,732.9	13,831.9	14,481.2	14,059.2	15,287.1	13,835.4	12,033.4	9,916	8,280.7
Contingent Liabilities	0	0	316.2	305.37	102.17	92.17	1,231.9	1,605.2	1,740	1,867.2

Cash Flow (Figures in Rs. Crores)

Consolidated
Standalone

Cash from Operating Activity 3,570.3

Net Profit before Tax and Extr...	2,883.5
Depreciation	1,228.8
Interest (Net)	14.4
P/L on Sales of Assets	4.2
Prov. and W/O (Net)	699.8
P/L in Forex	185.3
Others	-119.3
Total Adjustments (PBT and Ext...	2,087.2
Operating Profit before Workin...	4,970.7
Trade and 0ther Receivables	208.1
Inventories	-988.1
Trade Payables	286.1
Total Adjustments (OP before W...	-828.8
Cash Generated from/(used in) ...	4,141.9
Direct Taxes Paid	-571.6
Total Adjustments(Cash Generat...	-571.6
Cash Flow before Extraordinary...	3,570.3
Net Cash from Operating Activi...	3,570.3

Cash from Investing Activity -2,254.7

Purchased of Fixed Assets	-1,256.1
Sale of Fixed Assets	8.5
Purchase of Investments	-7,541.8
Sale of Investments	7,952.8
Interest Received	122
Net Cash used in Investing Act...	-2,254.7

Cash from Financing Activity -29.8

Proceeds from Issue of shares ...	26.9
Proceed from 0ther Long Term B...	380
Proceed from Short Tem Borrowi...	679.1
Of the Long Tem Borrowings	-374.3
Of Financial Liabilities	-75.4
Dividend Paid	-414.7
Interest Paid	-132.1
Net Cash used in Financing Act...	-29.8

Cash from Operating Activity 3,514.2

Net Profit before Tax and Extr...	3,056.2
Depreciation	835
Interest (Net)	-75.6
P/L on Sales of Assets	-471.1
Prov. and W/O (Net)	21.9
P/L in Forex	-44.3
Others	-119.3
Total Adjustments (PBT and Ext...	273.3
Operating Profit before Workin...	3,329.5
Trade and 0ther Receivables	713.7
Inventories	-582.7
Trade Payables	268
Total Adjustments (OP before W...	632.7
Cash Generated from/(used in) ...	3,962.2
Direct Taxes Paid	-448
Total Adjustments(Cash Generat...	-448
Cash Flow before Extraordinary...	3,514.2
Net Cash from Operating Activi...	3,514.2

Cash from Investing Activity -1,453.6

Purchased of Fixed Assets	-1,093.9
Sale of Fixed Assets	490
Purchase of Investments	-6,952
Sale of Investments	7,486.1
Interest Received	163.2
Net Cash used in Investing Act...	-1,453.6

Cash from Financing Activity -794.3

Proceeds from Issue of shares ...	26.9
Proceed from Short Tem Borrowi...	152.7
Of the Long Tem Borrowings	-374.3
Of Financial Liabilities	-3.8
Dividend Paid	-414.7
Interest Paid	-61.8
Net Cash used in Financing Act...	-794.3

Dr Reddys Laboratories News

Nifty Pharma Climbs 3% After RBI Announces Liquidity

May 5, 2021

Dr Reddy’s Laboratories Profit After Tax Surges 77% To Rs 504 Crores

October 29, 2018

Dr Reddy’s Sells Its Rights Of Cloderm Cream To EPI Health

October 3, 2018

Dr Reddy's Lab files lawsuit in the US District Court

May 28, 2018

Dr Reddy's Labs Q3 net profit declines 29% YoY

January 25, 2018

Company Details

Registered Office
Address	8-2-337 Road No 3, Banjara Hills
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Registrars
Address	8-2-337 Road No 3
City	Hyderabad
State	Telangana
Pin Code	500034
Tel. No.	91-40-49002900
Fax. No.	91-40-49002999
Email	shares@drreddys.com
Internet	http://www.drreddys.com

Management
Name	Designation
G V Prasad	Co-Chairman & Managing Directo
K Satish Reddy	Chairman
Kalpana Morparia	Independent Director
Sandeep Poddar	Company Secretary
Bruce L A Carter	Independent Director
Sridar Iyengar	Independent Director
Prasad R Menon	Independent Director
Shikha Sanjaya Sharma	Independent Director
Allan Oberman	Independent Director
Leo Puri	Independent Director
K P Krishnan	Independent Director

Related Links

Dr Reddys Laboratories Ltd Historical Data

Dr Reddys Laboratories Ltd Technical Chart

Top Stocks - Pharmaceuticals

MARKET TODAY

PRODUCTS

SUPPORT

LEGAL & PRIVACY

MAGAZINES

Stocks: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Data is a real-time snapshot *Data is delayed by at least 15 minutes. StockFact, Market Action Data and Analysis. Data Provider CMOTS Infotech.

Disclaimer : There is no guarantee of profits or no exceptions from losses. The investment advice provided is solely the personal views of the research team. Equitypandit will not accept any liability for loss or damage as a result of reliance on the information contained within this website including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Therefore, Equitypandit doesn’t bear any responsibility for any trading losses you might incur as a result of using this data.

@2022 -Equitypandit Media Corp. All Right Reserved.